ClinVar Miner

Submissions for variant NM_004444.5(EPHB4):c.2420G>A (p.Gly807Glu)

dbSNP: rs2116416678
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetics and Molecular Pathology, SA Pathology RCV002272690 SCV002556713 likely pathogenic Capillary malformation-arteriovenous malformation 2 2021-06-03 criteria provided, single submitter clinical testing The EPHB4 c.2420G>A variant is classified as LIKELY PATHOGENIC (PM1, PM2, PP3, PM5_Supporting) The EPHB4 c.2420G>A variant is a single nucleotide change in exon 14 of the EPHB4 gene, which is predicted to change the amino acid glycine at position 807 in the protein to glutamic acid. This variant is absent from population databases (PM2). This variant is located in the protein kinase catalytic domain and is predicted to impact protein function (PM1), and the different amino acid change p.Gly807Arg has been reported in two probands with arteriovenous malformations (Amyere et al, 2017; PMID:28687708). Computational predictions support a deleterious effect on the gene or gene product (PP3). This variant has not been reported in ClinVar or HGMD.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.